Coordinators of the 3 Campuses
PROF. ÁLVARO URBANO ISPIZUA
Campus Clínic-UB Scientific Coordinator
Professor Urbano specialised in hematology and hemotherapy at the Hospital Clínic in Barcelona, receiving his doctorate in 1989 with an extraordinary distinction. He was the senior consultant at this hospital until 2007 when he was appointed head of the Hematology Service at the Hospital Virgen del Rocío in Seville.
Between 1998 and 2004 he was secretary general of the European Bone Marrow Transplant Group (EBMT); between 2003 and 2005 he was vicepresident of the Spanish Hematology and Hemotherapy Society (AEHH); and between 2002 and 2006 he was president of the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and the European Group for Blood and Marrow Transplantation (EBMT) - JACIE.
Since March 2010 he has been Director of the Hematology and Oncology Institute at the Hospital Clínic in Barcelona and Titular
Professor of Medicine at the University of Barcelona. His scientific career commenced in 1990 and to date he has published more than 200 original articles with an impact factor of over 700 and an H-index factor of 35.
His work has been cited in over 2,000 articles. He also reviews numerous articles on bone marrow transplantation and cell therapy for a number of international scientific journals published in Spain and abroad.
PROF. EVARIST FELIU FRASNEDO
Campus ICO-Germans Trias i Pujol Scientific Coordinator
He joined the staff at the Hospital Germans Trias i Pujol en 1991 after previously having worked for 20 years at the Hematology Service of the Hospital Clínic in Barcelona, under the direction of professors Rozman and Vives Corrons. He did research apprenticeships at the University of Paris (Hôpital Beaujon) (1975-76) and at the University of Harvard (Massachusetts General Hospital) (1981-82).
He was also Head of the Hematology Service (1991-95), Medical Director (1995-97) and Managing Director (1997-2002) of the Germans Trias i Pujol University Hospital in Badalona. He was Director of a Catalan Oncology Institute Center, the Scientific Director of this institution and is currently Director of the University Relations Programme and head of the hematology- laboratory service.
Since 2008 he has been Chair of Medicine at the Autonomous University of Barcelona. He is the vice-president, patron and scientific director of the Josep Carreras Leukaemia Foundation and he chairs the Delegate Committee of the Josep Carreras
Leukaemia Research Institute. He presided the Spanish Hematology and Hemotherapy Society from 2008 to 2011.
Prof. Feliu contributes to major Spanish and international publications and has published more than 351 articles with an accumulated impact factor of 1,014.89 points and an H-index factor of 30. His work has been cited in over 2,706 articles.
PROF. JORDI SIERRA i GIL
Campus Sant Pau Scientific Coordinator
He joined the Hematology Service of the Hospital Clínic in Barcelona in 1985 as associate doctor and senior specialist. From 1995 to 1996 he completed his training at the Fred Hutchinson Cancer Research Center in Seattle, USA, and in 2013 at the Moffit Cancer Center in Tampa, Florida, USA.
Since 1997 he has directed the Hospital de Sant Pau Hematology Service and Hematopoietic Transplant Programme in
Barcelona. Since 2006 he has also been Professor at the Autonomous University of Barcelona. One year before he received a recognition for his Excellence from the College of Doctors of Barcelona. He is also Permanent Member of the Royal Academy of Medicine of Catalonia since 2017.
Prof. Sierra has been a member of the advisory board of the Center for International Blood and Marrow Transplant Research and of the Executive Committee of the European Hematology Association. Prof Sierra has published more than 390 articles in indexed journals and has accumulated an impact factor of over 1,350 with an H-index of 58. He has a number of mentions above 10.000. He has been the main researcher for more than 20 projects financed through competitive selection. He has been the president of the Spanish Hematology and Hemotherapy Society since 2016.